BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30563499)

  • 1. GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines.
    Cultrara CN; Kozuch SD; Ramasundaram P; Heller CJ; Shah S; Beck AE; Sabatino D; Zilberberg J
    BMC Cancer; 2018 Dec; 18(1):1263. PubMed ID: 30563499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of glucose-regulated protein 78/binding immunoglobulin heavy chain protein expression by asymmetric small interfering RNA induces apoptosis in prostate cancer cells and attenuates migratory capability.
    Lu T; Yang W; Wang Z; Hu Z; Zeng X; Yang C; Wang Y; Zhang Y; Li F; Liu Z; Wang D; Ye Z
    Mol Med Rep; 2015 Jan; 11(1):249-56. PubMed ID: 25338653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
    Yun S; Han YS; Lee JH; Kim S; Lee SH
    Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression.
    Wu CT; Wang WC; Chen MF; Su HY; Chen WY; Wu CH; Chang YJ; Liu HH
    Tumour Biol; 2014 Jan; 35(1):195-204. PubMed ID: 23922175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
    Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
    Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Cadherin and EpCAM.
    Voss G; Haflidadóttir BS; Järemo H; Persson M; Catela Ivkovic T; Wikström P; Ceder Y
    Carcinogenesis; 2020 Jul; 41(7):865-874. PubMed ID: 31738404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
    Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
    Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.
    Kuo LJ; Huang CY; Cheng WL; Hung CS; Wu CT; Lin FY; Chang YJ; Huang MT
    Tumour Biol; 2015 Jul; 36(7):5063-70. PubMed ID: 25669168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressed GRP78 affects EMT and cell-matrix adhesion via autocrine TGF-β/Smad2/3 signaling.
    Zhang L; Li Z; Fan Y; Li H; Li Z; Li Y
    Int J Biochem Cell Biol; 2015 Jul; 64():202-11. PubMed ID: 25934251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.
    Zoni E; Chen L; Karkampouna S; Granchi Z; Verhoef EI; La Manna F; Kelber J; Pelger RCM; Henry MD; Snaar-Jagalska E; van Leenders GJLH; Beimers L; Kloen P; Gray PC; van der Pluijm G; Kruithof-de Julio M
    Oncogene; 2017 Aug; 36(33):4739-4749. PubMed ID: 28394345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
    Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
    Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
    Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
    Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.
    Groen RW; de Rooij MF; Kocemba KA; Reijmers RM; de Haan-Kramer A; Overdijk MB; Aalders L; Rozemuller H; Martens AC; Bergsagel PL; Kersten MJ; Pals ST; Spaargaren M
    Haematologica; 2011 Nov; 96(11):1653-61. PubMed ID: 21828122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway.
    Chang YJ; Chen WY; Huang CY; Liu HH; Wei PL
    Tumour Biol; 2015 Mar; 36(3):1859-69. PubMed ID: 25431258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRP78 Participates in PCA3-regulated Prostate Cancer Progression.
    Lin C; Wang J; Wang Y; Zhu P; Liu X; Li N; Liu J; Yu L; Wang W
    Anticancer Res; 2017 Aug; 37(8):4303-4310. PubMed ID: 28739722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
    Sagredo AI; Sagredo EA; Pola V; Echeverría C; Andaur R; Michea L; Stutzin A; Simon F; Marcelain K; Armisén R
    J Cell Physiol; 2019 Mar; 234(3):2037-2050. PubMed ID: 30343491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.